Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Change in Inventory (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Change in Inventory for 16 consecutive years, with -$257000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory fell 180.56% year-over-year to -$257000.0, compared with a TTM value of -$1.9 million through Sep 2025, down 361.73%, and an annual FY2024 reading of $332000.0, up 128.23% over the prior year.
  • Change in Inventory was -$257000.0 for Q3 2025 at Rockwell Medical, up from -$885000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.5 million in Q1 2022 and bottomed at -$1.6 million in Q3 2023.
  • Average Change in Inventory over 5 years is $2000.0, with a median of $1000.0 recorded in 2024.
  • The sharpest move saw Change in Inventory skyrocketed 1056.86% in 2022, then crashed 999.3% in 2023.
  • Year by year, Change in Inventory stood at $102000.0 in 2021, then surged by 1056.86% to $1.2 million in 2022, then plummeted by 67.37% to $385000.0 in 2023, then crashed by 99.74% to $1000.0 in 2024, then crashed by 25800.0% to -$257000.0 in 2025.
  • Business Quant data shows Change in Inventory for RMTI at -$257000.0 in Q3 2025, -$885000.0 in Q2 2025, and -$733000.0 in Q1 2025.